Gastroenterology clinical trials recruiting in Texas

96 recruiting gastroenterology trials match in Texas. Showing 20.

• A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.Recruiting

  Phase 2 · Sanofi · Katy, Texas

• A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)Recruiting

  Phase 3 · 89bio, Inc. · Amarillo, Texas

• A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 2 · Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) · Cedar Park, Texas

• A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)Recruiting

  Phase 2 · GlaxoSmithKline · Corsicana, Texas

• Registry and Biorepository for IBD in Central TexasRecruiting

  N/A · University of Texas at Austin · Austin, Texas

• Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in ChildrenRecruiting

  Phase 2 · AbbVie · Houston, Texas

• A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative ColitisRecruiting

  Phase 2 · Pfizer · Abilene, Texas

• A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASHRecruiting

  Phase 3 · GlaxoSmithKline · Austin, Texas

• Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 2 · Abivax S.A. · Bellaire, Texas

• A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative ColitisRecruiting

  N/A · Janssen Scientific Affairs, LLC · Houston, Texas

• A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASHRecruiting

  Phase 2 · GlaxoSmithKline · Austin, Texas

• A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 2 / Phase 3 · Janssen Research & Development, LLC · Austin, Texas

• A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and FibrosisRecruiting

  Phase 3 · Akero Therapeutics, Inc · Amarillo, Texas

• A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLDRecruiting

  Phase 2 · Regeneron Pharmaceuticals · Georgetown, Texas

• An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative ColitisRecruiting

  N/A · Pfizer · Houston, Texas

• A Study of Efimosfermin Alfa in Adults With Hepatic ImpairmentRecruiting

  Phase 1 · GlaxoSmithKline · San Antonio, Texas

• A Study to Test Whether BI 3032950 Helps People With Ulcerative ColitisRecruiting

  Phase 2 · Boehringer Ingelheim · Cedar Park, Texas

• HB-adMSCs for the Treatment of Crohn's DiseaseRecruiting

  Phase 2 · Hope Biosciences Research Foundation · Sugar Land, Texas

• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 3 · Hoffmann-La Roche · Dallas, Texas

• Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk PopulationRecruiting

  N/A · Methodist Health System · Dallas, Texas

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.